CN112021568A - 用于辅助防疫新冠病毒的药食同源类功能性组合物 - Google Patents
用于辅助防疫新冠病毒的药食同源类功能性组合物 Download PDFInfo
- Publication number
- CN112021568A CN112021568A CN202010897350.8A CN202010897350A CN112021568A CN 112021568 A CN112021568 A CN 112021568A CN 202010897350 A CN202010897350 A CN 202010897350A CN 112021568 A CN112021568 A CN 112021568A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw materials
- enzymolysis
- agent
- meshes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 241000711573 Coronaviridae Species 0.000 title claims abstract description 25
- 230000002265 prevention Effects 0.000 title claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 86
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 75
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 75
- 235000008434 ginseng Nutrition 0.000 claims abstract description 75
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 74
- 241000234435 Lilium Species 0.000 claims abstract description 73
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 72
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 70
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 70
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims abstract description 68
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract description 68
- 239000002994 raw material Substances 0.000 claims abstract description 62
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 57
- 235000013305 food Nutrition 0.000 claims abstract description 40
- 239000003814 drug Substances 0.000 claims abstract description 24
- 238000000227 grinding Methods 0.000 claims abstract description 17
- 239000008187 granular material Substances 0.000 claims abstract description 10
- 240000005717 Dioscorea alata Species 0.000 claims abstract description 7
- 235000002723 Dioscorea alata Nutrition 0.000 claims abstract description 7
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims abstract description 7
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims abstract description 7
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims abstract description 7
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims abstract description 7
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 7
- 235000007056 Dioscorea composita Nutrition 0.000 claims abstract description 4
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 claims abstract description 4
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 claims abstract description 4
- 244000197580 Poria cocos Species 0.000 claims description 73
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 67
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 67
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 67
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 67
- 239000000796 flavoring agent Substances 0.000 claims description 36
- 239000003795 chemical substances by application Substances 0.000 claims description 34
- 235000013355 food flavoring agent Nutrition 0.000 claims description 34
- 235000003599 food sweetener Nutrition 0.000 claims description 34
- 239000003765 sweetening agent Substances 0.000 claims description 34
- 239000003755 preservative agent Substances 0.000 claims description 32
- 230000002335 preservative effect Effects 0.000 claims description 32
- 102000004190 Enzymes Human genes 0.000 claims description 29
- 108090000790 Enzymes Proteins 0.000 claims description 29
- 229940088598 enzyme Drugs 0.000 claims description 29
- 239000000843 powder Substances 0.000 claims description 26
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 24
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- 239000000047 product Substances 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 16
- 235000013376 functional food Nutrition 0.000 claims description 16
- 108010059892 Cellulase Proteins 0.000 claims description 13
- 108091005804 Peptidases Proteins 0.000 claims description 13
- 108010059820 Polygalacturonase Proteins 0.000 claims description 13
- 239000004365 Protease Substances 0.000 claims description 13
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 13
- 229940106157 cellulase Drugs 0.000 claims description 13
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 13
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 12
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 12
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 229960003080 taurine Drugs 0.000 claims description 12
- 229940026510 theanine Drugs 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 230000000415 inactivating effect Effects 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000006189 buccal tablet Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000003825 pressing Methods 0.000 claims description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 241000382455 Angelica sinensis Species 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 2
- 240000007049 Juglans regia Species 0.000 claims description 2
- 235000009496 Juglans regia Nutrition 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229940046011 buccal tablet Drugs 0.000 claims description 2
- 239000004330 calcium propionate Substances 0.000 claims description 2
- 235000010331 calcium propionate Nutrition 0.000 claims description 2
- 235000021433 fructose syrup Nutrition 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 235000001727 glucose Nutrition 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 235000019871 vegetable fat Nutrition 0.000 claims description 2
- 235000020234 walnut Nutrition 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 5
- 238000013329 compounding Methods 0.000 claims 1
- 230000007071 enzymatic hydrolysis Effects 0.000 claims 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 210000004072 lung Anatomy 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 208000011580 syndromic disease Diseases 0.000 abstract description 5
- 230000004069 differentiation Effects 0.000 abstract description 4
- 210000000056 organ Anatomy 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 69
- 210000000952 spleen Anatomy 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 8
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 7
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 210000002540 macrophage Anatomy 0.000 description 7
- 239000001630 malic acid Substances 0.000 description 7
- 235000011090 malic acid Nutrition 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- -1 tanshinone Chemical class 0.000 description 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 2
- 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000010388 propyl gallate Nutrition 0.000 description 2
- 239000000473 propyl gallate Substances 0.000 description 2
- 229940075579 propyl gallate Drugs 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 2
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 2
- QDCAPUNOYRYBGX-UHFFFAOYSA-N 1,1,1-trihydroxybutan-2-one Chemical compound CCC(=O)C(O)(O)O QDCAPUNOYRYBGX-UHFFFAOYSA-N 0.000 description 1
- SRUQARLMFOLRDN-UHFFFAOYSA-N 1-(2,4,5-Trihydroxyphenyl)-1-butanone Chemical compound CCCC(=O)C1=CC(O)=C(O)C=C1O SRUQARLMFOLRDN-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 1
- 102100039386 Ketimine reductase mu-crystallin Human genes 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- 101000772180 Lithobates catesbeianus Transthyretin Proteins 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000019823 konjac gum Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000001797 sucrose acetate isobutyrate Substances 0.000 description 1
- 235000010983 sucrose acetate isobutyrate Nutrition 0.000 description 1
- UVGUPMLLGBCFEJ-SWTLDUCYSA-N sucrose acetate isobutyrate Chemical compound CC(C)C(=O)O[C@H]1[C@H](OC(=O)C(C)C)[C@@H](COC(=O)C(C)C)O[C@@]1(COC(C)=O)O[C@@H]1[C@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@H](OC(=O)C(C)C)[C@@H](COC(C)=O)O1 UVGUPMLLGBCFEJ-SWTLDUCYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
- A23P10/47—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added using additives, e.g. emulsifiers, wetting agents or dust-binding agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于药食同源类功能性组合物技术领域,具体涉及一种用于辅助防疫新冠病毒的药食同源类功能性组合物。本发明的组合物,其主要原料为:百合、炒山药、当归、大枣、茯苓、人参;将上述的主要原料超微粉碎、酶解处理后,与新资源食品原料复配,然后加入辅料,混合均匀后形成粉状冲剂成品。本发明所提供的组合物,具有药食同源性;药食同源的食品,其安全性高;既可以作为药材使用,又是一种食材;从中医辨证出发,本发明的搭配,药性平和,从归于肺经的原料出发,选择的原料能作为一个整体调节身体的各个器官,使其共同发挥作用,对抗疫病尤其是针对于突发的新型冠状病毒疫病,具有良好的辅助治疗效果。
Description
技术领域
本发明属于药食同源类功能性组合物技术领域,具体涉及一种用于辅助防疫新冠病毒的药食同源类功能性组合物。
背景技术
新型冠状病毒,世界卫生组织正式将其命名为2019-nCoV,新型冠状病毒的表现形式为呼吸综合症和严重急性呼吸综合症等较严重的疾病,新型冠状病毒是以前从未在人体中发现的冠状病毒新毒株。
若是感染新型冠状病毒后,常见的症状为发热、咳嗽、气促和呼吸困难等;在较严重的病例中,可导致肺炎、严重急性呼吸综合症、肾衰竭,甚至死亡。目前对于新型冠状病毒并没有特异的治疗方法,但是根据结合临床情况可以对其进行辅助治疗,以达到对感染者进行护理、控制病情的目的。
在疫苗尚未大规模应用于人体中之前,辅助治疗新型冠状病毒,是非常有必要的;而在人类抗击疫情的过程中,西医治疗尚无对症的药物,此时,中医药发挥着自身的优势,对症处理,标本同治,扶正固体,收到了显著的疗效。这是因为,中医学遵循系统的整体观,认为人体是一个内外统一的整体,体内脏腑的生理病理变化可反映于外,以中医理论中的脏腑经络和精气和气血的生理病理为基础,辨症治疗,获得了良好的效果。此外,中医理论中的治未病先防方面也具有提高免疫力抗击疫情的作用,中医注重“防重于治、防治结合”,即在未病之前防止疾病发生,确定相应的治疗原则,以防止疾病的发展。
发明内容
为了解决上述的技术问题,本发明提供了一种用于辅助防疫新冠病毒的药食同源类功能性食品组合物;还提供了上述的食品组合物的制备方法;
本发明所提供的用于辅助防疫新冠病毒的药食同源类功能性食品组合物,该组合物中的主要原料为:百合、炒山药、当归、去核大枣、茯苓、人参;将上述的主要原料超微粉碎、酶解处理后,与新资源食品原料复配,然后加入辅料,混合均匀后形成粉状冲剂成品;或者是,将上述的粉状成品压制成含片的形式。
上述酶解所采用的酶类为纤维素酶、果胶酶、蛋白酶;纤维素酶、果胶酶、蛋白酶依次占主要原料的0.2~0.5%、0.1~0.3%、0.3~0.7%。
上述的主要原料的重量份数如下:
百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5。
优选的,百合6.5~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合7~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合7.5~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合8~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合8~10.5、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合8~10、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合9~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合9~10、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~10、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8.5~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药9~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~10.5、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~10、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药9~10、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3.5~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归4~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归4.5~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归5~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归5.5~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归6~9、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~8.5、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~8、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~7.5、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~7、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~6.5、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归4~6.5、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归5~6.5、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归5.5~6、去核大枣1~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1.5~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣2~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣2.5~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣3~6、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣3~5.5、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣3~5、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣3~4.5、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣3~4、茯苓1~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1.5~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓2~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓2.5~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓3~6、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓3~5.5、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓3~5、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓3~4.5、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓3~4、人参0.4~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.5~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.46~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.7~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.8~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.9~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参1.0~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参1.1~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参1.2~1.5;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.4;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.3;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.2;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.1;
优选的,百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.0;
优选的,百合9、炒山药9、当归6、去核大枣3、茯苓3、人参1;
超微粉碎至物料为400~800目。
新资源食品原料为牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸;牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占主要原料的1~4%、20~40%、3~8%、2~5%。
辅料为甜味剂、调味剂、防腐剂、防潮剂中的至少一种。
甜味剂为蔗糖、葡萄糖、果葡糖奖、麦芽糖醇中的任一种;
调味剂选自植脂末、核桃粉;
防腐剂选自山梨酸钾、苯甲酸、苯甲酸钠、丙酸钙中的任一种;
防潮剂选自麦芽糊精;
在制备本发明的食品组合物的过程中,所采用的辅料优选以上种类,但是并不仅限于上述种类的辅料,辅料还可以选自酸味剂,比如,柠檬酸、抗坏血酸、醋、酒石酸、柠檬酸钠、葡萄糖酸、苹果酸、乳酸等中的任一种或至少一种;
辅料还可以选自抗氧化剂,比如维生素C、维生素E、茶多酚、植物提取物比如丹参酮、银杏叶提取物、芦荟汁等;2,6一二叔丁基甲酚、叔丁基对羟基茴香醚、没食子酸丙酯(PG)、辛酯(OG)、十二酯(DG)、三羟基苯丁酮(THBP)、丁基羟基茴香醚(BHA)、二丁基羟基甲苯(BHT)、特丁基对苯二酚(TBHQ)中的任一种或至少一种;
辅料还可以选自稳定剂,比如黄原胶、果胶、卡拉胶、魔芋胶、CMC、羧甲基纤维素钠、结冷胶、瓜尔豆胶、琼脂、槐豆胶、蔗糖酯、乙酸异丁酸蔗糖酯中的任一种或至少一种;
辅料还可以采用食用香精,比如牛奶香精、花生香精、玉米香精、葡萄香精、蓝莓香料、水蜜桃香精、西瓜香精、苹果香精、桔子香精等中的任一种;
上述的用于辅助防疫新冠病毒的药食同源类功能性食品组合物的制备方法,包括以下的步骤:
S1:取百合、炒山药、当归、去核大枣、茯苓、人参,粉碎至20~40目;然后将粉碎的物料再次进行超微粉碎,超微粉碎至400~600目;
S2:在S1中获得的超微粉碎的原料中,按料液重量体积比1:8~12的比例加入水,调节温度至40~50℃,然后再加入复合酶,复合酶中纤维素酶、果胶酶、蛋白酶依次占待酶解原料的0.2~0.5%、0.1~0.3%、0.3~0.7%;酶解30~50min,酶解完成后,在95~100℃下灭酶5~10min;获得酶解液;
S3:取酶解的上清液,浓缩,干燥,超微粉碎至400~600目;
S4:取酶解下部的沉淀物质,干燥,超微粉碎至400~600目;
S5:将S3、S4中的物料混合均匀,得混合物料;然后再加入新资源食品原料;新资源食品原料中,牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占混合物料的1~4%、20~40%、3~8%、2~5%;
S6:将S5中获得的物料与辅料混合均匀,获得粉状冲剂成品;辅料为甜味剂、调味剂、防腐剂、防潮剂;
甜味剂、调味剂、防腐剂、防潮剂的用量为S5中获得的物料的2~6%;其中,甜味剂、调味剂、防腐剂、防潮剂的重量比例为15~25:8~15:0.02~0.07:15~25。
优选的,S2:在S1中获得的超微粉碎的原料中,按料液重量体积比1:8~12的比例加入水,调节温度至45℃,然后再加入复合酶,复合酶中纤维素酶、果胶酶、蛋白酶依次占待酶解原料的0.3%、0.25%、0.5%;酶解40min,酶解完成后,在95℃下灭酶8min;获得酶解液。
优选的,上述的制备方法,包括以下的步骤:
S1:取百合、炒山药、当归、去核大枣、茯苓、人参,粉碎至20~40目;然后将粉碎的物料再次进行超微粉碎,超微粉碎至400~600目;
S2:在S1中获得的超微粉碎的原料中,按料液重量体积比1:8~12的比例加入水,调节温度至45℃,然后再加入复合酶,复合酶中纤维素酶、果胶酶、蛋白酶依次占待酶解原料的0.3%、0.25%、0.5%;酶解40min,酶解完成后,在95℃下灭酶8min;获得酶解液;
S3:取酶解的上清液,浓缩,干燥,超微粉碎至400~600目;
S4:取酶解下部的沉淀物质,干燥,超微粉碎至400~600目;
S5:将S3、S4中的物料混合均匀,得混合物料;然后再加入新资源食品原料;新资源食品原料中,牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占混合物料的2.5%、30%、5%、4%;
S6:将S5中获得的物料与辅料混合均匀,获得粉状冲剂成品;辅料为甜味剂、调味剂、防腐剂、防潮剂;
甜味剂、调味剂、防腐剂、防潮剂的用量为S5中获得的物料的2~6%;其中,甜味剂、调味剂、防腐剂、防潮剂的重量比例为20:10:0.05:20。
优选的,本发明的食品组合物,还可以是片剂的形式;当食品组合物为片剂时,用于辅助防疫新冠病毒的药食同源类功能性食品组合物的制备方法,包括以下的步骤:
S1:取百合、炒山药、当归、去核大枣、茯苓、人参,粉碎至20~40目;然后将粉碎的物料再次进行超微粉碎,超微粉碎至400~600目;
S2:在S1中获得的超微粉碎的原料中,按料液重量体积比1:8~12的比例加入水,调节温度至45℃,然后再加入复合酶,复合酶中纤维素酶、果胶酶、蛋白酶依次占待酶解原料的0.3%、0.25%、0.5%;酶解40min,酶解完成后,在95℃下灭酶8min;获得酶解液;
S3:取酶解的上清液,浓缩,干燥,超微粉碎至400~600目;
S4:取酶解下部的沉淀物质,干燥,超微粉碎至400~600目;
S5:将S3、S4中的物料混合均匀,得混合物料;然后再加入新资源食品原料;新资源食品原料中,牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占混合物料的2.5%、30%、5%、4%;
S6:将S5中获得的物料与辅料混合均匀,获得粉状物料,将粉状物料压制成含片,每片1~1.5克;辅料为甜味剂、调味剂、防腐剂、防潮剂;
甜味剂、调味剂、防腐剂、防潮剂的用量为S5中获得的物料的2~6%;其中,甜味剂、调味剂、防腐剂、防潮剂的重量比例为20:10:0.05:20。
本发明的产品,不拘于以上形式的食品种类,除了粉状冲剂形式和片状形式的产品之外,还可以是其它形式的产品,比如还可以以本发明的原料来制作液体形式的口服液;像类似的变换也落在本发明的保护范围之内。
本发明所配伍的食药同源性的食品组合物,分别具有以下的特点:
百合,补肺阴,兼能清肺热,有养阴清肺、润燥止咳的功效;
炒山药,能够补脾健胃,因为从中医食疗的角度上来讲,炒山药性味甘、平,入脾经、胃经,通过滋补胃经和脾经,有很好的补脾健胃的功效;此外,山药还有除湿、补气、益肺、固肾、益精的功效;
当归,性甘、辛、湿;归肝经、心经、脾经;具有补血;活血;调经止痛;润燥滑肠的作用;
去核大枣,补脾和胃、益气生津;调营卫;补中益气、强力,除烦闷;疗心下悬;
茯苓,味甘、淡,性平;归心、肺、脾、肾经;生津液、开腠理,滋水源而下降、利小便;
人参,味甘微寒,主补五脏,安精神,定魂魄,止惊悸,除邪气,明目,开心益智。
本发明原料搭配的原理是,结合肾、脾胃,共同调理;肾藏先天之精,协调一身脏腑之阴阳;首先,本发明中采用了能养肾的原料,然后以能运化和消化水谷并输送精微并升举内脏的原料共同作用,燥湿相济,升降相因,纳运相助,共同完成饮食的消化吸收和精微的输布,化生气血,营养全身。在临床中,脾虚会影响到肺,若脾运化无力,容易形成水液代谢障碍,产生湿,所以,本发明中采用了炒山药和茯苓,化去湿气,以避免脾影响到肺,从而达到避免肺部生病或者是达到减轻肺部疾病的目的。
本发明在原料的选材上,遵循了以下的标准:
1.药食同源性;药食同源的食品,其安全性高;既可以作为药材使用,又是一种食材;
2.从中医辨证出发,本发明的搭配,药性平和,从归于肺经的原料出发,选择的原料能作为一个整体调节身体的各个器官,使其共同发挥作用,对抗疫病尤其是针对于突发的新型冠状病毒疫病,具有良好的辅助治疗效果;本发明中的产品集合了中医辨症理论、药食同源性理论,在配伍方面遵循君臣佐使的原则;不仅采用归于肺经的百合,还采用补益气血的当归、大枣;辅以除邪气的人参,以及去湿生津的茯苓和炒山药,从整体上固本扶正,结合补气与御邪,提高人体的免疫力,拒邪于外。
3.本发明所选择的原料药性平和,无明显的副作用,对于提高免疫力、抵抗力,防止外来疫病的侵扰,具有显著的辅助治疗作用。
具体实施方式
为了能使本领域技术人员更好的理解本发明,现结合具体实施方式对本发明进行更进一步的阐述。
实施例1
用于辅助防疫新冠病毒的药食同源类功能性食品组合物的制备方法,包括以下的步骤:
S1:取百合、炒山药、当归、去核大枣、茯苓、人参;各原料的重量份数为:百合9、炒山药9、当归6、去核大枣3、茯苓3、人参1;粉碎至20目;然后将粉碎的物料再次进行超微粉碎,超微粉碎至400目;
S2:在S1中获得的超微粉碎的原料中,按料液重量体积比1:10的比例加入水,调节温度至45℃,然后再加入复合酶,复合酶中纤维素酶、果胶酶、蛋白酶依次占待酶解原料的0.3%、0.25%、0.5%;酶解40min,酶解完成后,在95℃下灭酶8min;获得酶解液;
S3:取酶解的上清液,浓缩,干燥,超微粉碎至600目;
S4:取酶解下部的沉淀物质,干燥,超微粉碎至600目;
S5:将S3、S4中的物料混合均匀,得混合物料;然后再加入新资源食品原料;新资源食品原料中,牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占混合物料的2.5%、30%、5%、4%;
S6:将S5中获得的物料与辅料混合均匀,获得粉状冲剂成品;辅料为甜味剂、调味剂、防腐剂、防潮剂;
甜味剂、调味剂、防腐剂、防潮剂的用量为S5中获得的物料的6%;其中,甜味剂、调味剂、防腐剂、防潮剂的重量比例为20:12:0.05:20:0.2:1。
实施例2
在实施例1的基础上,增加了口感调节剂;其中,S6:S6:将S5中获得的物料与辅料混合均匀,获得粉状冲剂成品;辅料为甜味剂、调味剂、防腐剂、防潮剂、抗氧化剂Vc、苹果酸;
甜味剂、调味剂、防腐剂、防潮剂、抗氧化剂Vc、苹果酸的用量为S5中获得的物料的6%;其中,甜味剂、调味剂、防腐剂、防潮剂、抗氧化剂Vc、苹果酸的重量比例为20:12:0.05:20:0.2:1。
实施例3
当产品为片剂时,用于辅助防疫新冠病毒的药食同源类功能性食品组合物的制备方法,包括以下的步骤:
S1:取百合、炒山药、当归、去核大枣、茯苓、人参,粉碎至40目;然后将粉碎的物料再次进行超微粉碎,超微粉碎至400目;
S2:在S1中获得的超微粉碎的原料中,按料液重量体积比1:10的比例加入水,调节温度至45℃,然后再加入复合酶,复合酶中纤维素酶、果胶酶、蛋白酶依次占待酶解原料的0.3%、0.25%、0.5%;酶解40min,酶解完成后,在95℃下灭酶8min;获得酶解液;
S3:取酶解的上清液,浓缩,干燥,超微粉碎至600目;
S4:取酶解下部的沉淀物质,干燥,超微粉碎至600目;
S5:将S3、S4中的物料混合均匀,得混合物料;然后再加入新资源食品原料;新资源食品原料中,牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占混合物料的2.5%、30%、5%、4%;
S6:将S5中获得的物料与辅料混合均匀,获得粉状物料,将粉状物料压制成含片,每片1~1.5克;辅料为甜味剂、调味剂、防腐剂、防潮剂;
甜味剂、调味剂、防腐剂、防潮剂的用量为S5中获得的物料的6%;其中,甜味剂、调味剂、防腐剂、防潮剂的重量比例为20:10:0.05:20。
实施例4
在实施例1的基础上,增加了口感调节剂;其中,S6:S6:将S5中获得的物料与辅料混合均匀,获得粉状冲剂成品;辅料为甜味剂、调味剂、防腐剂、防潮剂、抗氧化剂Vc、苹果酸、稳定剂黄原胶;
甜味剂、调味剂、防腐剂、防潮剂、抗氧化剂Vc、苹果酸、黄原胶的用量为S5中获得的物料的6%;其中,甜味剂、调味剂、防腐剂、防潮剂、抗氧化剂Vc、苹果酸、稳定剂的重量比例为20:12:0.05:20:0.2:0.005。
实施例5
5.1以RAW267.4巨噬细胞为对象开展细胞增殖和LPS诱导的炎性因子IL-1β表达水平分析。
细胞增殖采用MTT法来测定;按常规方法分离制备下列生物样本,包括:昆明大鼠和正常人(健康人群)外周血巨噬细胞(单核细胞);
MTT颜色反应
参照Mosmann法,在不同细胞数和培养体系条件下进行实验和结果比较,将巨噬细胞调成不细胞浓度,计算存活率,加于24孔平底培养板,每份样本设平行样。置于37℃、5%的CO2培养后进行MTT颜色反应,于570nm比色测定光密度(OD)分析比较;
结果分析方法:
以各样本的测定孔ODs减对照孔ODc,求得差值△OD,进行组内平均和组间比较(t检验),并计算增殖指数,SI=△OD/ODc×100%和单位细胞增殖力CCP= ODc/细胞数×108,以评价巨噬细胞的增殖功能。
表1 巨噬细胞的增殖功能MTT法检测结果
细胞浓度(×10<sup>8</sup>mL) | 细胞量(mL/孔) | △OD | SI(%) | 重复实验RSD(%) | |
健康人群 | 2.0 | 1.0 | 0.014±0.008 | 5.32±1.1 | 8.5~11.0 |
实施例1 | 8.0 | 1.2 | 0.032±0.011 | 12.07±2.4 | 6.0~15.0 |
实施例2 | 8.0 | 1.2 | 0.041±0.009 | 16.4±1.8 | 5.0~10.0 |
实施例3 | 8.0 | 1.2 | 0.037±0.003 | 14.2±2.3 | 9.0~13.0 |
实施例4 | 8.0 | 1.2 | 0.031±0.008 | 12.9±1.66 | 12.5~18.0 |
考察不同浓度的产品对于RAW267.4细胞增殖的影响,浓度为800μg/mL的产品与对照组相比,存活率差异有统计学意义。各浓度的产品与对照组相比差异均有统计学意义。
5.2关于本发明的产品对于RAW267.4巨噬细胞炎性因子表达水平的影响,实验结果如下表2 ;其中,给药按以下标准进行:
将对数生长期的RAW267.4细胞分别按每孔6×106个培养接种到6孔细胞培养板中,随机分为空白对照组,低、中、高剂量组(10、100、1000ng·mL-1),加入药物后将细胞放入二氧化碳培养箱中孵育2小时,然后每孔加入10μg·mL-1样品继续培养10小时,备用。
表2 本发明的产品对于RAW267.4巨噬细胞炎性因子表达水平的影响
组别 | IL-1/ng·L<sup>-1</sup> | IL-6/ng·L<sup>-1</sup> | TNF-α/ng·L<sup>-1</sup> |
空白对照组 | 38.16±6.8 | 35.29±4.5 | 32.15±6.8 |
低剂量组 | 143.66±15.48** | 89.46±18.57** | 48.3±11.5** |
中剂量组 | 95.39±17.4<sup>△△</sup> | 67±13.2<sup>△▲</sup> | 48.6±8.8<sup>△△▲</sup> |
高剂量组 | 51.34±8.76<sup>△▲</sup> | 34.5±7.3<sup>△▲▲●</sup> | 27.5±3.6<sup>△▲▲▲●</sup> |
**P<0.01;▲P<0.05;▲▲P<0.01;△P<0.05;△△P<0.01;●P<0.05。
从以上表格中的数据可以看出,本发明的产品对于RAW267.4巨噬细胞释放的1L-1、1L-6、TNF-α均有不同程度的抑制作用。与空白对照例相比, 低、中、高剂量组均能不同程度的抑制炎性因子的释放,且作用强度与剂量呈现正相关,各组之间的差异具有统计学意义。
从以上的表格中的数据来看,本发明所提供的食品组合物,具有食用方便、效果优异的特点;或以粉末冲剂状冲服或以含片形式含服,经过口感搭配和调节,使得其口感也乐于被人接受。同时,本发明的配方在于辅助治疗和治未病,具有治疗和预防双重作用,应用开发前景广阔。
Claims (10)
1.用于辅助防疫新冠病毒的药食同源类功能性食品组合物,其特征在于,所述的组合物中的主要原料为:百合、炒山药、当归、去核大枣、茯苓、人参;将上述的主要原料超微粉碎、酶解处理后,与新资源食品原料复配,然后加入辅料,混合均匀后形成粉状成品;或者是,将上述的粉状成品压制成含片的形式。
2.如权利要求1所述的用于辅助防疫新冠病毒的药食同源类功能性食品组合物,其特征在于,酶解时所采用的酶类为纤维素酶、果胶酶、蛋白酶;纤维素酶、果胶酶、蛋白酶依次占主要原料的0.2~0.5%、0.1~0.3%、0.3~0.7%。
3.如权利要求1所述的用于辅助防疫新冠病毒的药食同源类功能性食品组合物,其特征在于,所述的主要原料的重量份数如下:
百合6~11、炒山药8~11、当归3~9、去核大枣1~6、茯苓1~6、人参0.4~1.5。
4.如权利要求1所述的用于辅助防疫新冠病毒的药食同源类功能性食品组合物,其特征在于,超微粉碎至物料为400~800目。
5.如权利要求1所述的用于辅助防疫新冠病毒的药食同源类功能性食品组合物,其特征在于,新资源食品原料为牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸;牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占主要原料的1~4%、20~40%、3~8%、2~5%。
6.如权利要求1所述的用于辅助防疫新冠病毒的药食同源类功能性食品组合物,其特征在于,辅料为甜味剂、调味剂、防腐剂、防潮剂中的至少一种。
7.如权利要求1所述的用于辅助防疫新冠病毒的药食同源类功能性食品组合物,其特征在于,甜味剂为蔗糖、葡萄糖、果葡糖奖、麦芽糖醇中的任一种;
调味剂选自植脂末、核桃粉;
防腐剂选自山梨酸钾、苯甲酸、苯甲酸钠、丙酸钙中的任一种;
防潮剂选自麦芽糊精。
8.用于辅助防疫新冠病毒的药食同源类功能性食品组合物的制备方法,包括以下的步骤:
S1:取百合、炒山药、当归、去核大枣、茯苓、人参,粉碎至20~40目;然后将粉碎的物料再次进行超微粉碎,超微粉碎至400~600目;
S2:在S1中获得的超微粉碎的原料中,按料液重量体积比1:8~12的比例加入水,调节温度至40~50℃,然后再加入复合酶,复合酶中纤维素酶、果胶酶、蛋白酶依次占待酶解原料的0.2~0.5%、0.1~0.3%、0.3~0.7%;酶解30~50min,酶解完成后,在95~100℃下灭酶5~10min;获得酶解液;
S3:取酶解的上清液,浓缩,干燥,超微粉碎至400~600目;
S4:取酶解下部的沉淀物质,干燥,超微粉碎至400~600目;
S5:将S3、S4中的物料混合均匀,得混合物料;然后再加入新资源食品原料;新资源食品原料中,牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占混合物料的1~4%、20~40%、3~8%、2~5%;
S6:将S5中获得的物料与辅料混合均匀,获得粉状冲剂成品;辅料为甜味剂、调味剂、防腐剂、防潮剂;
甜味剂、调味剂、防腐剂、防潮剂的用量为S5中获得的物料的2~6%;其中,甜味剂、调味剂、防腐剂、防潮剂的重量比例为15~25:8~15:0.02~0.07:15~25。
9.如权利要求8所述的制备方法,其特征在于,包括以下的步骤:
S1:取百合、炒山药、当归、去核大枣、茯苓、人参,粉碎至20~40目;然后将粉碎的物料再次进行超微粉碎,超微粉碎至400~600目;
S2:在S1中获得的超微粉碎的原料中,按料液重量体积比1:8~12的比例加入水,调节温度至45℃,然后再加入复合酶,复合酶中纤维素酶、果胶酶、蛋白酶依次占待酶解原料的0.3%、0.25%、0.5%;酶解40min,酶解完成后,在95℃下灭酶8min;获得酶解液;
S3:取酶解的上清液,浓缩,干燥,超微粉碎至400~600目;
S4:取酶解下部的沉淀物质,干燥,超微粉碎至400~600目;
S5:将S3、S4中的物料混合均匀,得混合物料;然后再加入新资源食品原料;新资源食品原料中,牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占混合物料的2.5%、30%、5%、4%;
S6:将S5中获得的物料与辅料混合均匀,获得粉状冲剂成品;辅料为甜味剂、调味剂、防腐剂、防潮剂;
甜味剂、调味剂、防腐剂、防潮剂的用量为S5中获得的物料的2~6%;其中,甜味剂、调味剂、防腐剂、防潮剂的重量比例为20:10:0.05:20。
10.用于辅助防疫新冠病毒的药食同源类功能性食品组合物的制备方法,包括以下的步骤:
S1:取百合、炒山药、当归、去核大枣、茯苓、人参,粉碎至20~40目;然后将粉碎的物料再次进行超微粉碎,超微粉碎至400~600目;
S2:在S1中获得的超微粉碎的原料中,按料液重量体积比1:8~12的比例加入水,调节温度至45℃,然后再加入复合酶,复合酶中纤维素酶、果胶酶、蛋白酶依次占待酶解原料的0.3%、0.25%、0.5%;酶解40min,酶解完成后,在95℃下灭酶8min;获得酶解液;
S3:取酶解的上清液,浓缩,干燥,超微粉碎至400~600目;
S4:取酶解下部的沉淀物质,干燥,超微粉碎至400~600目;
S5:将S3、S4中的物料混合均匀,得混合物料;然后再加入新资源食品原料;新资源食品原料中,牛磺酸、蛋白粉、谷氨酰胺、低聚异麦芽糖茶氨酸依次占混合物料的2.5%、30%、5%、4%;
S6:将S5中获得的物料与辅料混合均匀,获得粉状物料,将粉状物料压制成含片,每片1~1.5克;辅料为甜味剂、调味剂、防腐剂、防潮剂;
甜味剂、调味剂、防腐剂、防潮剂的用量为S5中获得的物料的2~6%;其中,甜味剂、调味剂、防腐剂、防潮剂的重量比例为20:10:0.05:20。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010897350.8A CN112021568A (zh) | 2020-08-31 | 2020-08-31 | 用于辅助防疫新冠病毒的药食同源类功能性组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010897350.8A CN112021568A (zh) | 2020-08-31 | 2020-08-31 | 用于辅助防疫新冠病毒的药食同源类功能性组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112021568A true CN112021568A (zh) | 2020-12-04 |
Family
ID=73586418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010897350.8A Pending CN112021568A (zh) | 2020-08-31 | 2020-08-31 | 用于辅助防疫新冠病毒的药食同源类功能性组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112021568A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113057244A (zh) * | 2021-04-29 | 2021-07-02 | 山东省现代中药研究院有限公司 | 一种具有免疫调节作用的压片糖果制备工艺 |
CN115053962A (zh) * | 2022-05-27 | 2022-09-16 | 白山关东药厂 | 一种参针粉、制备方法及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106578093A (zh) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | 一种创伤、感染、手术及其它应激状态专用型临床营养配方及其制备方法 |
CN108497502A (zh) * | 2018-04-17 | 2018-09-07 | 陕西三正医用营养有限公司 | 一种中药复合谷氨酰胺特殊膳食食品及其制备方法 |
CN110916189A (zh) * | 2019-12-25 | 2020-03-27 | 吉林大学 | 一种具有润肺功能的人参方便食品的制备方法 |
CN111558026A (zh) * | 2020-03-29 | 2020-08-21 | 王学昌 | 一种预防新冠肺炎等疾病,同时提升阳气、补益筋骨、促进健康的“新雄黄”中药饮品 |
-
2020
- 2020-08-31 CN CN202010897350.8A patent/CN112021568A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106578093A (zh) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | 一种创伤、感染、手术及其它应激状态专用型临床营养配方及其制备方法 |
CN108497502A (zh) * | 2018-04-17 | 2018-09-07 | 陕西三正医用营养有限公司 | 一种中药复合谷氨酰胺特殊膳食食品及其制备方法 |
CN110916189A (zh) * | 2019-12-25 | 2020-03-27 | 吉林大学 | 一种具有润肺功能的人参方便食品的制备方法 |
CN111558026A (zh) * | 2020-03-29 | 2020-08-21 | 王学昌 | 一种预防新冠肺炎等疾病,同时提升阳气、补益筋骨、促进健康的“新雄黄”中药饮品 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113057244A (zh) * | 2021-04-29 | 2021-07-02 | 山东省现代中药研究院有限公司 | 一种具有免疫调节作用的压片糖果制备工艺 |
CN115053962A (zh) * | 2022-05-27 | 2022-09-16 | 白山关东药厂 | 一种参针粉、制备方法及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101152007B (zh) | 一种保健品组合物及其制备方法 | |
US9950024B2 (en) | Traditional Chinese medicine composition and the use thereof | |
CN109966417A (zh) | 一种针对糖尿病人群的固体饮料 | |
CN109480281A (zh) | 一种有机黑果枸杞酵素及其制备方法 | |
CN104642654A (zh) | 一种控制体重并降低尿酸降三高保健茶 | |
CN112021568A (zh) | 用于辅助防疫新冠病毒的药食同源类功能性组合物 | |
CN105851743A (zh) | 一种清心润肺保健饮料及其制备方法 | |
CN111149968A (zh) | 一种健康固体饮料及其制备方法 | |
CN103783370B (zh) | 一种保护呼吸道和肺部的组合物 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN115486541B (zh) | 一种具有美白功效的草本益生菌组合物及其制备方法 | |
CN100506085C (zh) | 一种能够提高产妇免疫力的红糖保健品 | |
CN107997153A (zh) | 一种黄精复合保健食品及其制备方法 | |
CN114081924A (zh) | 一种调理气血的发酵产品及其制备方法和应用 | |
CN115399476A (zh) | 一种具有辅助润肠通便功能的食品组合物 | |
CN105661496A (zh) | 一种高丽红参白芷细胞破壁超微粉的制备方法 | |
CN106668332B (zh) | 一种百香果含片及其制备方法 | |
NL2037306B1 (en) | A nutritional product for clearing and protecting the lungs and a preparation method thereof | |
CN115105575B (zh) | 一种山药黄精草本组合物、山药黄精破壁草本代用茶及其制备方法 | |
CN115671206B (zh) | 一种用于缓解疲劳的中药肽口服液及其制备方法 | |
CN110755523B (zh) | 一种改善高血糖的组合物及其制备方法 | |
Mazurenko et al. | Products for children with infectious diseases. Technologies and assortment | |
CN105661495A (zh) | 一种高丽红参肉桂细胞破壁超微粉的制备方法 | |
CN114668144A (zh) | 一种降糖复合植物酵素、制备方法及应用 | |
CN118044609A (zh) | 一种缓解疲劳的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201204 |